Patient with a sudden drop in blood pressure

Critical Care Medicine

Volumn 31, Issue 1, 2003, Pages 326-327

  Oliver, Juan A ^a   Landry, Donald W ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Blood pressure; Sepsis; Shock; Terlipressin; Vasopressin

Indexed keywords

DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; TERLIPRESSIN; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

AORTA FLOW; CARDIOGENIC SHOCK; CLINICAL TRIAL; EDITORIAL; HEART OUTPUT; HUMAN; HYPOTENSION; HYPOVOLEMIC SHOCK; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SEPTIC SHOCK; SURVIVAL; VASODILATATION;

ANIMALS; FLUID THERAPY; HUMANS; HYPOTENSION; LYSINE VASOPRESSIN; RATS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 0037253125     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200301000-00062     Document Type: Editorial

References (16)

1. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
2. Argenziano M, Chowdri AF, Oz MC, et al: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96(Suppl 2) II-286-II-290
3. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001:345:1368-1377
4. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
5. Landry DW, Levin HR, Gallant EM, et al: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-1282
6. Morales DLS, Madigan J, Cullinane S, et al: Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation 1999; 199:226-229
7. Malay MB, Ashton RCJ, Landry DW, et al: Low-dose vasopressin (VP) in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-703
8. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487-493
9. Dunser MW, Mayr AJ, Ulmer H, et al: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 2001; 93:7-13
10. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
11. Scharte M, Meyer J, Van Aken H, et al: Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29:1756-1760
12. O'Brien A, Clapp L, Singer S: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210
13. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
14. Asfar P, Pierrot M, Veal N, et al: Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003; 31:215-220
15. Wilson MF, Brackett DJ, Archer LT, et al: Mechanisms of impaired cardiac function by vasopressin. Ann Surg 1980; 191:494-500
16. Avontuur JAM, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Cir Rest 1995; 76:418-425